| ID/Version |
|
||||||||||||||
|
Sequence description from provider |
RecName: Full=Urocortin-2;AltName: Full=Urocortin II {ECO:0000303|PubMed:11226328}; Short=Ucn II {ECO:0000303|PubMed:11226328};Flags: Precursor; | ||||||||||||||
| Provider | SWISS-PROT | ||||||||||||||
| Sequence |
Polypeptide
113
aa
|
||||||||||||||
| Source | |||||||||||||||
| Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
| Sequence references in MGI |
J:67860
Reyes TM, et al., Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2843-8
J:116101 Chen A, et al., Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16580-5 J:132850 Hao Z, et al., Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation. Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3939-44 J:166245 Neufeld-Cohen A, et al., A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19020-5 J:383051 Vaughan JM, et al., Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products. Endocrinology. 2013 Apr;154(4):1553-64 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 06/16/2026 MGI 6.24 |
|
|
|
||